Loteperdnol CAS 82034-46-6 is suitable for the treatment of eye cornea, conjunctiva and anterior inflammation. Loteperdnol is susceptible to hydrolyze to inactive organic. It will metabolize rapidly to inactive products when it applied to eyes. Loteperdnol reduce the systemic toxicity and have stronger anti-inflammatory effect than prednisolone. We have started to produce in mass quantity and have a certain scale in stock. Micronized and sterility are our productive standard.

Thera. Category: Anti-inflammatory

Cas No.: 82034-46-6

Synonym: LOTEPREDNOL ETABONATE;chloromethyl 17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthrene-17-carboxylate;CDDD-5604, HGP-1, P-5604, Alrex, Lotemax;Androsta-1,4-diene-17-carboxylicacid,17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxo-,chloromethylester,;Chloromethyl 17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-17-carboxylate;Androsta-1,4-diene-17-carboxylic acid, 17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxo-, chloromethyl ester, (11b,17a)-;Lotemax;17α-(Ethoxycarbonyloxy)-11β-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylic acid chloromethyl ester

Molecular Formula: C24H31ClO7

Molecular Weight: 466.95

Specifications: Available on request

Packing: Export worthy packing

Material Safety Data Sheet: Available on request

Usage: An ophthalmic corticosteroid. It is used for the treatment of steroid responsive inflammatory conditions of the eye